http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114369092-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86275eeefdb9bf80d8eb1862aa48055f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C303-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C303-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-61
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-61
filingDate 2021-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15a78b3d01717e8404964bf7afeb1a12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5318729b701780bdb3d5b86d96dd8e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dda5baf961d2427273d27615857f1eae
publicationDate 2022-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114369092-A
titleOfInvention Tosufloxacin tosylate and preparation method thereof
abstract The invention provides tosufloxacin tosylate and a preparation method thereof, wherein the preparation method comprises the following steps: carrying out amination reaction by using acetic anhydride, triethyl orthoformate, fluorochlorotinate, methanol and 2, 4-difluoroaniline as initial raw materials to prepare tosufloxacin tosylate amino; preparing a tosufloxacin tosylate cyclic compound through a cyclization reaction based on an amine base; preparing a tosufloxacin tosylate substituent by a substitution reaction based on a cyclic compound; and (3) preparing a crude product of the tosufloxacin tosylate by hydrolysis salifying reaction based on the substituent, and refining to obtain the tosufloxacin tosylate. The preparation method disclosed by the invention covers all steps of a synthesis route of the tosufloxacin tosylate, and a complete production chain is formed by designing all steps of the synthesis route, so that the prepared tosufloxacin tosylate has the advantages of low impurity content, high purity and high yield, and meets the high quality requirement of the medicine field on medicines.
priorityDate 2021-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420782350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451176864
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409908092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518507
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9709
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16212596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451674871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425172137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6420096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31214
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21955
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85570

Total number of triples: 60.